drugset / Trial / NCT00068952
Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this clinical trial is to study Edotecarin in patients with the brain tumor glioblastoma multiforme (GBM) who have progression or first recurrence following initial treatment with surgery, radiation and chemotherapy.
Timeline
- Start
- 2003-08
- Primary completion
- —
- Completion
- 2006-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Edotecarin | Small molecule | — | Intravenous |
| Subject | Lomustine | Small molecule | — | — |
| Subject | Temozolomide | Small molecule | — | — |
| Subject | carmustine | Small molecule | — | — |